Security key
097702203
Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT)
CUSIP: 097702203
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.00001 par value
- Shares outstanding
- 1,901,870
- Total 13F shares
- 602,538
- Share change
- -259,998
- Total reported value
- $3,295,047
- Price per share
- $5.47
- Number of holders
- 21
- Value change
- -$1,398,347
- Number of buys
- 5
- Number of sells
- 10
Report period
Q4 2025
Institutions
21
Top holders
10
BOLT full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Bolt Biotherapeutics, Inc. SEC filings
Bolt Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 097702203
Recent filing periods:
Top shareholders of BOLT - Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
13D/G
|
Company |
3.5%
from 13D/G
|
66,879
|
$355,796 | — | 30 Sep 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
9.3%
|
176,064
|
$936,660 | — | 30 Sep 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
7.2%
|
137,721
|
$732,676 | — | 30 Sep 2025 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
5%
|
94,573
|
$503,128 | — | 30 Sep 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
3.1%
|
58,347
|
$310,406 | — | 30 Sep 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
2.6%
|
48,830
|
$259,776 | — | 30 Sep 2025 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
1.9%
|
35,978
|
$191,400 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
34,231
|
$182,109 | — | 30 Sep 2025 | |
| PFIZER INC |
13F
|
Company |
1.6%
|
31,305
|
$166,543 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
28,625
|
$152,285 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.97%
|
18,533
|
$98,614 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.88%
|
16,642
|
$88,535 | — | 30 Sep 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.84%
|
15,958
|
$84,897 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.78%
|
14,836
|
$78,928 | — | 30 Sep 2025 | |
| DRW Securities, LLC |
13F
|
Company |
0.65%
|
12,322
|
$65,553 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.51%
|
9,711
|
$51,662 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
3,128
|
$16,641 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
259
|
$1,378 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
42
|
$223 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
31
|
$165 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
10
|
$53 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
6
|
$32 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
3
|
$16 | — | 30 Sep 2025 | |
| SALEM INVESTMENT COUNSELORS INC |
13F
|
Company |
0%
|
2
|
$11 | — | 30 Sep 2025 | |
| Vivo Capital VIII, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
5,763,311
mixed-class rows
|
$5,435,517 | — | 21 Nov 2023 | |
| Novo Holdings A/S |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,703,991
|
$3,518,791 | — | 13 Jul 2022 | |
| Edgar Engleman |
3/4/5
|
Director |
—
mixed-class rows
|
2,098,005
mixed-class rows
|
$1,969,355 | — | 29 Nov 2023 | |
| Edith A. Perez |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
281,612
mixed-class rows
|
$36,451 | — | 04 Mar 2024 | |
| Randall C. Schatzman |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
247,859
mixed-class rows
|
$10,056 | — | 04 Mar 2024 | |
| David Dornan |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
210,000
|
— | — | 18 Feb 2022 | |
| Richard A. Miller MD |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 12 Jun 2023 | |
| Frank D. Lee |
3/4/5
|
Director |
—
class O/S missing
|
22,000
|
— | — | 12 Jun 2024 | |
| James Healy |
3/4/5
|
Director |
—
class O/S missing
|
22,000
|
— | — | 12 Jun 2024 | |
| Mahendra Shah |
3/4/5
|
Director |
—
class O/S missing
|
22,000
|
— | — | 12 Jun 2024 | |
| Brian O'Callaghan |
3/4/5
|
Director |
—
class O/S missing
|
1,100
|
— | — | 12 Dec 2025 | |
| Jakob Dupont |
3/4/5
|
Director |
—
class O/S missing
|
1,100
|
— | — | 12 Dec 2025 | |
| Kathleen Laporte |
3/4/5
|
Director |
—
class O/S missing
|
1,100
|
— | — | 12 Dec 2025 | |
| Laura Berner |
3/4/5
|
Director |
—
class O/S missing
|
1,100
|
— | — | 12 Dec 2025 | |
| Nicole Onetto |
3/4/5
|
Director |
—
class O/S missing
|
1,100
|
— | — | 12 Dec 2025 |
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) as of Q4 2025
As of 31 Dec 2025,
Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
602,538 shares.
The largest 10 holders included
Sofinnova Investments, Inc., Pivotal bioVenture Partners Investment Advisor LLC, Vivo Capital, LLC, Nan Fung Group Holdings Ltd, RENAISSANCE TECHNOLOGIES LLC, T3 Companies, LLC, Board of Trustees of The Leland Stanford Junior University, Pfizer Inc, NANO CAP NEW MILLENNIUM GROWTH FUND L P, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
24
Q4 2025 holders
21
Holder diff
-3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.